Aprogen Medicines Inc. (KRX:007460)
South Korea flag South Korea · Delayed Price · Currency is KRW
293.00
-24.00 (-7.57%)
Apr 15, 2026, 9:54 AM KST

Aprogen Medicines Cash Flow Statement

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Net Income
-70,202-58,079-55,619-98,657-93,920
Upgrade
Depreciation & Amortization
23,59724,30529,07128,39225,262
Upgrade
Loss (Gain) From Sale of Assets
2,786201.14-30.3457.39-
Upgrade
Asset Writedown & Restructuring Costs
739.83801.872,2719,162223.61
Upgrade
Loss (Gain) From Sale of Investments
-1,749-303-341.932,7441,228
Upgrade
Loss (Gain) on Equity Investments
39,375--1,4899,543
Upgrade
Stock-Based Compensation
1,1521,7181,613707.672,445
Upgrade
Provision & Write-off of Bad Debts
384.751,573-8.5-5,001-
Upgrade
Other Operating Activities
-56,850-18,663-19,249-35,587-17,926
Upgrade
Change in Accounts Receivable
3,558-207.691,7493,395778.84
Upgrade
Change in Inventory
-4,0301,270-5,024-17,526-8,367
Upgrade
Change in Accounts Payable
-2,683-4,369-3,491-1,8523,378
Upgrade
Change in Income Taxes
-222.7-217.8935.78770.88
Upgrade
Change in Other Net Operating Assets
31,4876,761-9,315-2,151-8,155
Upgrade
Operating Cash Flow
-32,657-44,992-58,156-113,491-84,740
Upgrade
Capital Expenditures
-8,994-12,671-25,514-19,610-34,392
Upgrade
Sale of Property, Plant & Equipment
373.3483.042,273131.6540.06
Upgrade
Cash Acquisitions
-5,080-127.87-39,940-
Upgrade
Divestitures
58,122300-29,285-
Upgrade
Sale (Purchase) of Intangibles
-11,931-10,473-29,371-5,209-474.06
Upgrade
Investment in Securities
-59,583-9,486965.6827,26818,390
Upgrade
Other Investing Activities
-36,702-8,1308,193-1,690-924.3
Upgrade
Investing Cash Flow
-63,795-40,504-43,45270,172-12,790
Upgrade
Short-Term Debt Issued
37,50011,05014,61096,500134,190
Upgrade
Long-Term Debt Issued
158,83536,35096,546-30,845
Upgrade
Total Debt Issued
196,33547,400111,15696,500165,035
Upgrade
Short-Term Debt Repaid
-12,300-11,350-40,110-7,500-27,000
Upgrade
Long-Term Debt Repaid
-82,560-12,967-8,481-1,873-30,220
Upgrade
Total Debt Repaid
-94,860-24,317-48,591-9,373-57,220
Upgrade
Net Debt Issued (Repaid)
101,47523,08362,56587,127107,815
Upgrade
Issuance of Common Stock
-0.765,51530.972,583
Upgrade
Repurchase of Common Stock
--0.1--15,791-
Upgrade
Dividends Paid
-0.08----
Upgrade
Other Financing Activities
1,46763,53726,216-561.9-0
Upgrade
Financing Cash Flow
102,94186,62194,29670,804110,398
Upgrade
Foreign Exchange Rate Adjustments
1,497352.04-72.93-309.074.05
Upgrade
Net Cash Flow
7,9871,477-7,38527,17612,872
Upgrade
Free Cash Flow
-41,651-57,662-83,669-133,101-119,132
Upgrade
Free Cash Flow Margin
-35.30%-38.41%-55.57%-169.88%-453.05%
Upgrade
Free Cash Flow Per Share
-2100.28-3350.77-5314.11-9864.93-10307.07
Upgrade
Cash Interest Paid
2,821630.7242.7610,99211,339
Upgrade
Cash Income Tax Paid
2,921220.01-2,1283,291398.92
Upgrade
Levered Free Cash Flow
-91,444-41,649-21,656-145,21326,095
Upgrade
Unlevered Free Cash Flow
-88,467-41,019-21,261-139,02239,697
Upgrade
Change in Working Capital
28,1103,454-15,862-17,199-11,594
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.